HealthEquity Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, HealthEquity stock has a consensus rating of "Buy" and an average price target of $115.56. The average 1-year stock price forecast is 32.87% higher than the current stock price, while the lowest is $88 (+1.18%) and the highest is $135 (+55.23%).

Price Target: $115.56 (+32.87%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$88	$115.56	$113	$135
Change	+1.18%	+32.87%	+29.93%	+55.23%

Analyst Ratings

The average analyst rating for HealthEquity stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	9	9	9	10	10	10
Buy	5	5	5	5	5	5
Hold	1	1	1	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	16	16	16	16	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stan Berenshteyn Wells Fargo	Wells Fargo	Buy Reiterates $125	Buy	Reiterates	$125	+43.73%	Jun 5, 2026
Ryan Halsted RBC Capital	RBC Capital	Buy Reiterates $108	Buy	Reiterates	$108	+24.18%	Jun 3, 2026
Peter Warendorf Barclays	Barclays	Buy Reiterates $110	Buy	Reiterates	$110	+26.48%	Jun 3, 2026
Constantine Davides Citizens JMP	Citizens JMP	Buy Maintains $110 → $111	Buy	Maintains	$110 → $111	+27.63%	Jun 1, 2026
Alexander Paris Barrington	Barrington	Buy Reiterates $110	Buy	Reiterates	$110	+26.48%	May 29, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.42B

from 1.31B

7.76%

from 1.31B

Revenue Next Year

1.53B

from 1.42B

7.92%

from 1.42B

EPS This Year

4.73

from 4.00

18.31%

from 4.00

EPS Next Year

5.49

from 4.73

16.03%

from 4.73

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jan 31, 2022	Jan 31, 2023	Jan 31, 2024	Jan 31, 2025	Jan 31, 2026	Jan 31, 2027
Revenue	756.56M	861.75M	999.59M	1.20B	1.31B	1.42B
Revenue Growth	3.13%	13.90%	16.00%	20.03%	9.47%	7.76%
Gross Profit	424.77M	491.94M	622.64M	777.26M	913.12M	1.02B
Gross Margin	56.14%	57.09%	62.29%	64.78%	69.52%	72.08%
Operating Income	40.57M	37.65M	128.13M	202.87M	327.48M	375.99M
Net Income	-44.29M	-26.14M	55.71M	96.70M	215.20M	249.38M
EPS	-	-	-	-	4.00	4.73
EPS Growth	-	-	-	-	28.21%	18.31%
Forward PE	40.27	36.76	28.55	31.70	19.75	18.38
Free Cash Flow	69.70M	69.65M	211.89M	-145.32M	338.05M	429.88M
No. Analysts	-	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2027	2028	2029
High	1.4B
Avg	1.4B
Low	1.4B

Revenue Growth

Revenue Growth	2027	2028	2029
High	8.1%
Avg	7.8%
Low	7.3%

EPS Forecast

EPS	2027	2028	2029
High	4.93
Avg	4.73
Low	4.66

EPS Growth

EPS Growth	2027	2028	2029
High	23.3%
Avg	18.3%
Low	16.5%